• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Greenhill & Co. Inc. (Amendment)

    8/18/22 10:01:22 AM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance
    Get the next $GHL alert in real time by email
    SC 13D/A 1 amendment8tosc13d.htm SC 13D/A Document

     
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    Schedule 13D
    (Rule 13d-101)
    Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and
    Amendments Thereto Filed Pursuant to § 240.13d-2(a)
    Under the Securities Exchange Act of 1934
    (Amendment No. 8)*
     
    Greenhill & Co., Inc.
    (Name of Issuer)
    Common Stock, par value $0.01 per share
    (Title of Class of Securities)
    395259104
    (CUSIP Number)
    Scott L. Bok
    c/o Greenhill & Co., Inc.
    1271 Avenue of the Americas
    New York, New York 10020
    (212) 389-1500
    with a copy to:
    Harold J. Rodriguez, Jr.
    Greenhill & Co., Inc.
    1271 Avenue of the Americas
    New York, New York 10020
    (212) 389-1500
    (Name, address and telephone number of person authorized to receive notices and communications)
    August 15, 2022
    (Date of Event which Requires Filing of this Statement)
     
    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ☐.
     
    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.
     
     
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
     
     




    CUSIP No. 395259104  13D  Page 1 of 13
     
      1   
      Names of Reporting Persons
     
      Scott L. Bok
      2 
      Check the Appropriate Box If a Member of a Group (See Instructions)
      a.  ☒        b.  ☐
     
      3 
      SEC Use Only
     
      4 
      Source of Funds (See Instructions)
     
      PF
      5 
      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
     
      ☐
      6 
      Citizenship or Place of Organization
     
      United States of America
    Number of
    Shares
     Beneficially 
    Owned By
    Each
    Reporting
    Person
    With
     
        7    
      Sole Voting Power
     
      302,598
        8  
      Shared Voting Power
     
      2,420,755
        9  
      Sole Dispositive Power
     
      302,598
      10  
      Shared Dispositive Power
     
      2,420,755
    11   
      Aggregate Amount Beneficially Owned by Each Reporting Person
     
      2,723,353
    12 
      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
     
      ☐
    13 
      Percent of Class Represented By Amount in Row (11)
     
      15.2%
    14 
      Type of Reporting Person (See Instructions)
     
      IN





    CUSIP No. 395259104  13D  Page 2 of 13
     
      1   
      Names of Reporting Persons
     
      Bok Family Partners, L.P.
      2 
      Check the Appropriate Box If a Member of a Group (See Instructions)
      a.  ☒        b.  ☐
     
      3 
      SEC Use Only
     
      4 
      Source of Funds (See Instructions)
     
      AF, WC
      5 
      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
     
      ☐
      6 
      Citizenship or Place of Organization
     
      Delaware
    Number of
    Shares
     Beneficially 
    Owned By
    Each
    Reporting
    Person
    With
     
        7    
      Sole Voting Power
     
      None
        8  
      Shared Voting Power
     
      1,536,449
        9  
      Sole Dispositive Power
     
      None
      10  
      Shared Dispositive Power
     
      1,536,449
    11   
      Aggregate Amount Beneficially Owned by Each Reporting Person
     
      1,536,449
    12 
      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
     
      ☐
    13 
      Percent of Class Represented By Amount in Row (11)
     
      8.6%
    14 
      Type of Reporting Person (See Instructions)
     
      PN






    CUSIP No. 395259104  13D  Page 3 of 13
     
      1   
      Names of Reporting Persons
     
      Bok Family Foundation
      2 
      Check the Appropriate Box If a Member of a Group (See Instructions)
      a.  ☒        b.  ☐
     
      3 
      SEC Use Only
     
      4 
      Source of Funds (See Instructions)
     
      AF
      5 
      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
     
      ☐
      6 
      Citizenship or Place of Organization
     
      Connecticut
    Number of
    Shares
     Beneficially 
    Owned By
    Each
    Reporting
    Person
    With
     
        7    
      Sole Voting Power
     
      None
        8  
      Shared Voting Power
     
      288,783
        9  
      Sole Dispositive Power
     
      None
      10  
      Shared Dispositive Power
     
     288,783
    11   
      Aggregate Amount Beneficially Owned by Each Reporting Person
     
      288,783
    12 
      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
     
      ☐
    13 
      Percent of Class Represented By Amount in Row (11)
     
      1.6%
    14 
      Type of Reporting Person (See Instructions)
     
      OO






    CUSIP No. 395259104  13D  Page 4 of 13
     
      1   
      Names of Reporting Persons
     
      Scott L. Bok March 2020 Annuity Trust
      2 
      Check the Appropriate Box If a Member of a Group (See Instructions)
      a.  ☒        b.  ☐
     
      3 
      SEC Use Only
     
      4 
      Source of Funds (See Instructions)
     
      AF
      5 
      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
     
      ☐
      6 
      Citizenship or Place of Organization
     
      New York
    Number of
    Shares
     Beneficially 
    Owned By
    Each
    Reporting
    Person
    With
     
        7    
      Sole Voting Power
     
     132,639
        8  
      Shared Voting Power
     
      None
        9  
      Sole Dispositive Power
     
     132,639
      10  
      Shared Dispositive Power
     
      None
    11   
      Aggregate Amount Beneficially Owned by Each Reporting Person
     
     132,639
    12 
      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
     
      ☐
    13 
      Percent of Class Represented By Amount in Row (11)
     
      0.7%
    14 
      Type of Reporting Person (See Instructions)
     
      OO






    CUSIP No. 395259104  13D  Page 5 of 13
     
      1   
      Names of Reporting Persons
     
      Scott L. Bok November 2020 Annuity Trust
      2 
      Check the Appropriate Box If a Member of a Group (See Instructions)
      a.  ☒        b.  ☐
     
      3 
      SEC Use Only
     
      4 
      Source of Funds (See Instructions)
     
      AF
      5 
      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
     
      ☐
      6 
      Citizenship or Place of Organization
     
      New York
    Number of
    Shares
     Beneficially 
    Owned By
    Each
    Reporting
    Person
    With
     
        7    
      Sole Voting Power
     
      324,528
        8  
      Shared Voting Power
     
      None
        9  
      Sole Dispositive Power
     
      324,528
      10  
      Shared Dispositive Power
     
      None
    11   
      Aggregate Amount Beneficially Owned by Each Reporting Person
     
      324,528
    12 
      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
     
      ☐
    13 
      Percent of Class Represented By Amount in Row (11)
     
      1.8%
    14 
      Type of Reporting Person (See Instructions)
     
      OO






    CUSIP No. 395259104  13D  Page 6 of 13
     
      1   
      Names of Reporting Persons
     
      Scott L. Bok November 2021 Annuity Trust
      2 
      Check the Appropriate Box If a Member of a Group (See Instructions)
      a.  ☒        b.  ☐
     
      3 
      SEC Use Only
     
      4 
      Source of Funds (See Instructions)
     
      AF
      5 
      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
     
      ☐
      6 
      Citizenship or Place of Organization
     
      New York
    Number of
    Shares
     Beneficially 
    Owned By
    Each
    Reporting
    Person
    With
     
        7    
      Sole Voting Power
     
      138,356
        8  
      Shared Voting Power
     
      None
        9  
      Sole Dispositive Power
     
      138,356
      10  
      Shared Dispositive Power
     
      None
    11   
      Aggregate Amount Beneficially Owned by Each Reporting Person
     
     138,356
    12 
      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
     
      ☐
    13 
      Percent of Class Represented By Amount in Row (11)
     
      0.8%
    14 
      Type of Reporting Person (See Instructions)
     
      OO






    CUSIP No. 395259104  13D  Page 7 of 13
     
    Explanatory Note
    The purpose of this Amendment No. 8 (this “Amendment No. 8”) to the Schedule 13D filed with the U.S. Securities and Exchange Commission on January 10, 2018, as amended on June 26, 2018, November 13, 2018, August 22, 2019, January 16, 2020, August 25, 2020, November 15, 2021 and May 26, 2022 (the “Schedule 13D”) is to reflect an increase in the percentage of the shares of Common Stock, par value $0.01 per share (the “Shares”), of Greenhill & Co., Inc., a Delaware corporation (the “Issuer”), beneficially owned by the Reporting Persons. The increase in the percentage of the Shares beneficially owned by the Reporting Persons since the Schedule 13D was last amended on May 26, 2022, is attributable to (i) Bok Family Partners, L.P.’s purchase on the open market of 32,529 Shares on August 8, 2022, 50,000 Shares on August 9, 2022, and 37,450 shares on August 10, 2022; (ii) Scott L. Bok's purchase in the open market of 38,000 Shares on August 15, 2022, 40,000 Shares on August 16, 2022, and 32,430 shares on August 17, 2022; and (iii) a decrease in the outstanding Shares. Except as set forth below, all Items of the Schedule 13D remain unchanged. Capitalized terms used in this Amendment No. 8 and not otherwise defined shall have the respective meanings assigned to such terms in the Schedule 13D.





    CUSIP No. 395259104  13D  Page 8 of 13
     
    Item 2.Identity and Background
    The table set forth under Item 2 is hereby amended and restated as follows:
    Reporting Person  Address of Principal
    Office / Business or
    Residence Address
      
    Jurisdiction of
    Organization /
    Citizenship
      
    Occupation and
    Name / Address
    of Employer
      Principal Business
    Scott L. Bok  c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  United States of America  Chairman and Chief Executive Officer of Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  Investment Banking
    Bok Family Partners, L.P.  c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  Delaware  N/A  Holding Company
    Bok Family Foundation  c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  Connecticut  N/A  Charitable Foundation
    Scott L. Bok
    March 2020
    Annuity Trust
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  New York  N/A  Grantor Retained Annuity Trust Holding Assets for the Benefit of Scott L. Bok and His Two Children
    Scott L. Bok
    November 2020
    Annuity Trust
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  New York  N/A  Grantor Retained Annuity Trust Holding Assets for the Benefit of Scott L. Bok and His Two Children
    Scott L. Bok
    November 2021
    Annuity Trust
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  New York  N/A  Grantor Retained Annuity Trust Holding Assets for the Benefit of Scott L. Bok and His Two Children




    CUSIP No. 395259104  13D  Page 9 of 13
    Reporting Person  Address of Principal
    Office / Business or
    Residence Address
      
    Jurisdiction of
    Organization /
    Citizenship
      
    Occupation and
    Name / Address
    of Employer
      Principal Business
    Bok Family Partners, L.P.
    Control Persons
    Scott L. Bok,
    General Partner
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  See above.  See above.  See above.
    Bok Family Foundation
    Control Persons
    Scott L. Bok,
    Trustee
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  See above.  See above.  See above.
    Roxanne Bok,
    Trustee
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  United States of America  Not employed.  N/A
    Elliot Peter Bok,
    Trustee
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  United States of America  Senior Associate, CBRE Group, 200 Park Avenue, New York, NY 10166  Commercial Real Estate Services
    Scott L. Bok March 2020 Annuity Trust
    Control Persons
    Scott L. Bok,
    Trustee
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  See above.  See above.  See above.
    Scott L. Bok November 2020 Annuity Trust
    Control Persons
    Scott L. Bok,
    Trustee
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  See above.  See above.  See above.
    Scott L. Bok November 2021 Annuity Trust
    Control Persons
    Scott L. Bok,
    Trustee
      c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020  See above.  See above.  See above.




    CUSIP No. 395259104  13D  Page 10 of 13
     
    Item 3.Source and Amount of Funds or Other Consideration.
    Item 3 is hereby amended to add the following:
    On August 8, 2022, Bok Family Partners, L.P. purchased 17,534 Shares through a broker on the open market at a price per share of $8.96. The source of funds for such purchase was working capital of Bok Family Partners, L.P.
    On August 8, 2022, Bok Family Partners, L.P. purchased 14,995 Shares through a broker on the open market at a price per share of $8.64. The source of funds for such purchase was working capital of Bok Family Partners, L.P.
    On August 9, 2022, Bok Family Partners, L.P. purchased 50,000 Shares through a broker on the open market at a price per share of $8.89. The source of funds for such purchase was working capital of Bok Family Partners, L.P.
    On August 10, 2022, Bok Family Partners, L.P. purchased 37,450 Shares through a broker on the open market at a price per share of $8.90. The source of funds for such purchase was working capital of Bok Family Partners, L.P.
    On August 15, 2022, Scott L. Bok purchased 38,000 Shares through a broker on the open market at a price per share of $8.80. The source of funds for such purchase was personal funds of Scott L. Bok.
    On August 16, 2022, Scott L. Bok purchased 40,000 Shares through a broker on the open market at a price per share of $9.02. The source of funds for such purchase was personal funds of Scott L. Bok.
    On August 17, 2022, Scott L. Bok purchased 32,430 Shares through a broker on the open market at a price per share of $8.83. The source of funds for such purchase was personal funds of Scott L. Bok.
     
    Item 5.Interest in Securities of the Issuer.
    Item 5 is hereby amended and restated as follows:
    (a) See Item 9 on the Cover Pages to this Amendment No. 8. Percentages are based on 17,936,308 Shares outstanding as of August 17, 2022.
    As of the date hereof, the Reporting Persons beneficially own 2,723,353 Shares as a group, representing approximately 15.2% of the outstanding Shares.
    Scott L. Bok. Scott L. Bok is the direct beneficial owner of 302,598 Shares, representing approximately 1.7% of the outstanding Shares.
    Bok Family Partners, L.P. Scott L. Bok controls Bok Family Partners, L.P. Bok Family Partners, L.P. is the direct beneficial owner of 1,536,449 Shares, representing approximately 8.6% of the outstanding Shares.
    Bok Family Foundation. Scott L. Bok controls the Bok Family Foundation. The Bok Family Foundation is the direct beneficial owner of 288,783 Shares, representing approximately 1.6%of the outstanding Shares.





    CUSIP No. 395259104  13D  Page 11 of 13
    Scott L. Bok March 2020 Annuity Trust. Scott L. Bok controls the Scott L. Bok March 2020 Annuity Trust. The Scott L. Bok March 2020 Annuity Trust is the direct beneficial owner of 132,639 Shares, representing approximately 0.7% of the outstanding Shares.
    Scott L. Bok November 2020 Annuity Trust. Scott L. Bok controls the Scott L. Bok November 2020 Annuity Trust. The Scott L. Bok November 2020 Annuity Trust is the direct beneficial owner of 324,528 Shares, representing approximately 1.8% of the outstanding Shares.
    Scott L. Bok November 2021 Annuity Trust. Scott L. Bok controls the Scott L. Bok November 2021 Annuity Trust. The Scott L. Bok November 2021 Annuity Trust is the direct beneficial owner of 138,356 Shares, representing approximately 0.8% of the outstanding Shares.
    (b) Number of Shares as to which each Reporting Person has:
    (i) Sole power to vote or to direct the vote: See item 7 on the Cover Pages to this Amendment No. 8.
    (ii) Shared power to vote or to direct the vote: See item 8 on the Cover Pages to this Amendment No. 8.
    (iii) Sole power to dispose or to direct the disposition: See item 9 on the Cover Pages to this Amendment No. 8.
    (iv) Shared power to dispose or to direct the disposition: See item 10 on the Cover Pages to this Amendment No. 8.
    (c) On August 8, 2022, Bok Family Partners, L.P. purchased 17,534 Shares through a broker on the open market at a price per share of $8.96.
    On August 8, 2022, Bok Family Partners, L.P. purchased 14,995 Shares through a broker on the open market at a price per share of $8.64.
    On August 9, 2022, Bok Family Partners, L.P. purchased 50,000 Shares through a broker on the open market at a price per share of $8.89.
    On August 10, 2022, Bok Family Partners, L.P. purchased 37,450 Shares through a broker on the open market at a price per share of $8.90.
    On August 15, 2022, Scott L. Bok purchased 38,000 Shares through a broker on the open market at a price per share of $8.80.
    On August 16, 2022, Scott L. Bok purchased 40,000 Shares through a broker on the open market at a price per share of $9.02.
    On August 17, 2022, Scott L. Bok purchased 32,430 Shares through a broker on the open market at a price per share of $8.83.
    Except as described in this Item 5(c), there have been no transactions in Shares effected during the past 60 days by any of the Reporting Persons.
     



    CUSIP No. 395259104  13D  Page 12 of 13

    Item 6.Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
    Equity Incentive Plans. As the Chairman and Chief Executive Officer of the Issuer, Scott L. Bok is eligible to receive awards under the Issuer’s Equity Incentive Plans, which were adopted to motivate employees of the Issuer and allow them to participate in the ownership of Shares. The Amended 2019 Equity Incentive Plan became effective upon its approval by the Issuer’s stockholders at the Issuer’s annual meeting on April 27, 2022 (the “Amended 2019 Equity Incentive Plan”) and, together with the Issuer’s 2019 Equity Incentive Plan (the “2019 Equity Incentive Plan”) the “Equity Incentive Plans”). The Amended 2019 Equity Incentive Plan amended the Issuer’s existing 2019 Equity Incentive Plan approved by the Issuer’s stockholders at the Issuer’s annual meeting on April 24, 2019. The Amended 2019 Equity Incentive Plan is administered by the Compensation Committee, which has the authority, either directly or through its delegates, to grant equity awards to eligible persons including employees and directors. Awards under the Amended 2019 Equity Incentive Plan may be granted in the form of stock options, restricted stock, restricted stock units, performance awards, or other stock-based awards.
    The maximum number of Shares that may be issued under the Amended 2019 Equity Incentive Plan in respect of awards granted thereunder is 8,158,887, which figure includes (i) 4,500,000 plus (ii) 2,178,468 Shares remaining available for issuance under the 2019 Equity Incentive Plan plus (iii) 1,480,419 Shares that were not issued under the 2019 Equity Incentive Plan that may now be offered or sold under the Amended 2019 Equity Incentive Plan, subject to certain adjustments for major corporate transactions or awards which are cancelled, terminated, forfeited, fail to vest or are otherwise not paid or settled for any reason. Awards granted under the Equity Incentive Plans generally vest ratably over a period of four to five years beginning on the first anniversary of the grant date or in full on the third, fourth or fifth anniversary of the grant date. The default treatment under the Equity Incentive Plans provides that awards shall fully vest upon a termination of employment as a result of death or disability and that awards are forfeited upon any other termination of employment outside of the change in control context.
    This summary of the Equity Incentive Plans is qualified in its entirety by reference to the Amended 2019 Equity Incentive Plan and the 2019 Equity Incentive Plan, copies of which are attached hereto as Exhibit 9, Exhibit 5 and Exhibit 1, respectively, and incorporated herein by reference.





    CUSIP No. 395259104  13D  Page 13 of 13
     
    SIGNATURES
    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
    Date: August 18, 2022
     
    Scott L. Bok
    By: /s/ Scott L. Bok
    Name: Scott L. Bok
    Bok Family Partners, L.P.
    By: /s/ Scott L. Bok
    Name: Scott L. Bok
    Title: General Partner
    Bok Family Foundation
    By: /s/ Scott L. Bok
    Name: Scott L. Bok
    Title: Trustee
    Scott L. Bok March 2020 Annuity Trust
    By: /s/ Scott L. Bok
    Name: Scott L. Bok
    Title: Trustee
    Scott L. Bok November 2020 Annuity Trust
    By: /s/ Scott L. Bok
    Name: Scott L. Bok
    Title: Trustee
    Scott L. Bok November 2021 Annuity Trust
    By: /s/ Scott L. Bok
    Name: Scott L. Bok
    Title: Trustee








    EXHIBIT INDEX
     
    Exhibit
    Number
      Description
    1  Amended and Restated Equity Incentive Plan (incorporated by reference to Exhibit A to the Issuer’s Definitive Proxy Statement on Schedule 14A, filed on March 13, 2015).*
    2  Form of Greenhill & Co., Inc. Equity Incentive Plan Restricted Stock Unit Award Notification (incorporated by reference to Exhibit 10.4 to the Issuer’s Current Report on Form 8-K filed on September 26, 2017).*
    3  Joint Filing Agreement, dated January 10, 2018, by and among the Reporting Persons.*
    4  Joinder Agreement, dated November 13, 2018, to the Joint Filing Agreement.*
    5  Greenhill & Co., Inc. 2019 Equity Incentive Plan (incorporated by reference to Exhibit A to the Issuer’s Definitive Proxy Statement on Schedule 14A, filed on March 20, 2019).*
    6  Joinder Agreement, dated August 21, 2019, to the Joint Filing Agreement.*
    7  Joinder Agreement, dated August 25, 2020, to the Joint Filing Agreement.*
    8  Joinder Agreement, dated November 15, 2021 to the Joint Filing Agreement*
    9Greenhill & Co., Inc. Amended 2019 Equity Incentive Plan (incorporated by reference to Exhibit A to the Issuer's Definitive Proxy Statement on Schedule 14A, filed on March 14, 2022)*
     
    *Previously filed.


    Get the next $GHL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GHL

    DatePrice TargetRatingAnalyst
    4/28/2022$16.50 → $12.00Mkt Perform → Underperform
    Keefe Bruyette
    3/9/2022$18.50 → $17.00Neutral
    Piper Sandler
    7/14/2021$15.50Underperform → Market Perform
    Keefe, Bruyette & Woods
    More analyst ratings

    $GHL
    SEC Filings

    See more
    • SEC Form 15-12G filed by Greenhill & Co. Inc.

      15-12G - GREENHILL & CO INC (0001282977) (Filer)

      12/11/23 4:03:05 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form S-8 POS filed by Greenhill & Co. Inc.

      S-8 POS - GREENHILL & CO INC (0001282977) (Filer)

      12/1/23 8:44:25 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form S-8 POS filed by Greenhill & Co. Inc.

      S-8 POS - GREENHILL & CO INC (0001282977) (Filer)

      12/1/23 8:41:52 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Financials

    Live finance-specific insights

    See more
    • Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

      Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

      2/19/25 8:00:00 AM ET
      $DOC
      $GHL
      $HCP
      $ING
      Real Estate Investment Trusts
      Real Estate
      Investment Bankers/Brokers/Service
      Finance
    • Greenhill & Co. Reports Second Quarter 2023 Results

      Announced definitive agreement for Greenhill to be acquired by Mizuho Financial Group, Inc. in an all-cash transaction at $15 per share Quarterly revenues of $71.4 million, up 98% from prior year's second quarter Year to date revenues of $121.1 million, up 49% from the same period in 2022 Compensation ratio of 54% for the quarter; 82% for the year to date period Operating margin of 21% for the quarter Recruited two additional Managing Directors during the quarter Greenhill & Co., Inc. (NYSE:GHL) today reported revenues of $71.4 million, net income of $4.4 million and diluted earnings per share of $0.21 for the quarter ended June 30, 2023. The Firm's second quarter

      8/9/23 4:05:00 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Lifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECT

      NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of CWBR and Morphogenesis, Inc. Under the terms of the proposed merger, CWBR shareholders will receive a dividend equal to approximately 3.30 shares of CWBR common stock. Following the merger, pre-merger CohBar shareholders are expected to own approximately 15% of the outstanding equity of the combined company. If you are a CWBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-

      6/3/23 8:17:00 PM ET
      $CWBR
      $GHL
      $PDCE
      $VECT
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Greenhill & Co. Inc. (Amendment)

      SC 13G/A - GREENHILL & CO INC (0001282977) (Subject)

      7/17/23 4:18:36 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13D/A filed by Greenhill & Co. Inc. (Amendment)

      SC 13D/A - GREENHILL & CO INC (0001282977) (Subject)

      5/22/23 5:28:29 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by Greenhill & Co. Inc. (Amendment)

      SC 13G/A - GREENHILL & CO INC (0001282977) (Subject)

      1/9/23 11:41:53 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

      Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

      2/19/25 8:00:00 AM ET
      $DOC
      $GHL
      $HCP
      $ING
      Real Estate Investment Trusts
      Real Estate
      Investment Bankers/Brokers/Service
      Finance
    • Greenhill & Co. Reports Second Quarter 2023 Results

      Announced definitive agreement for Greenhill to be acquired by Mizuho Financial Group, Inc. in an all-cash transaction at $15 per share Quarterly revenues of $71.4 million, up 98% from prior year's second quarter Year to date revenues of $121.1 million, up 49% from the same period in 2022 Compensation ratio of 54% for the quarter; 82% for the year to date period Operating margin of 21% for the quarter Recruited two additional Managing Directors during the quarter Greenhill & Co., Inc. (NYSE:GHL) today reported revenues of $71.4 million, net income of $4.4 million and diluted earnings per share of $0.21 for the quarter ended June 30, 2023. The Firm's second quarter

      8/9/23 4:05:00 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Lifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECT

      NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of CWBR and Morphogenesis, Inc. Under the terms of the proposed merger, CWBR shareholders will receive a dividend equal to approximately 3.30 shares of CWBR common stock. Following the merger, pre-merger CohBar shareholders are expected to own approximately 15% of the outstanding equity of the combined company. If you are a CWBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-

      6/3/23 8:17:00 PM ET
      $CWBR
      $GHL
      $PDCE
      $VECT
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Ferro Kevin returned 81,495 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - GREENHILL & CO INC (0001282977) (Issuer)

      12/1/23 9:08:03 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Wyles David returned 98,707 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - GREENHILL & CO INC (0001282977) (Issuer)

      12/1/23 9:05:56 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Ekman Ulrika returned 10,205 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - GREENHILL & CO INC (0001282977) (Issuer)

      12/1/23 9:03:36 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Greenhill downgraded by Keefe Bruyette with a new price target

      Keefe Bruyette downgraded Greenhill from Mkt Perform to Underperform and set a new price target of $12.00 from $16.50 previously

      4/28/22 6:12:12 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Piper Sandler reiterated coverage on Greenhill & Co with a new price target

      Piper Sandler reiterated coverage of Greenhill & Co with a rating of Neutral and set a new price target of $17.00 from $18.50 previously

      3/9/22 6:45:52 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Greenhill & Co upgraded by Keefe, Bruyette & Woods with a new price target

      Keefe, Bruyette & Woods upgraded Greenhill & Co from Underperform to Market Perform and set a new price target of $15.50

      7/14/21 5:05:57 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance